James H. Mackaness, Chief Financial Officer at SOLENO THERAPEUTICS INC (SLNO), sold 64,964 shares at $37.06 ($2.4M) on 2023-12-11, disclosed to the SEC on 2023-12-13.
Open-market sale of $2.4M SLNO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.49 | 6,252 | $222K | 9.4% |
| 2 | $35.49 | 6,252 | $222K | 9.4% |
| 3 | $36.16 | 12,381 | $448K | 18.9% |
| 4 | $36.16 | 12,381 | $448K | 18.9% |
| 5 | $37.06 | 13,849 | $513K | 21.7% |
| 6 | $37.06 | 13,849 |
| $513K |
| 21.7% |
| Total | $36.41 avg | 64,964 | $2.4M | 100% |
| Filing → |
| SLNO | SELL | 2024-10-03 | $757K | — | Filing → |
| SLNO | SELL | 2024-08-30 | $1.1M | — | Filing → |
| SLNO | SELL | 2024-08-07 | $1.3M | — | Filing → |